The National Cancer Research Institute (NCRI) is a partnership of UK cancer research funders who work together to ensure that their funding is used to the best effect. Since 2002, this funding has amounted to more than £4.5bn of cancer research.
HSC R&D is one of the partners within NCRI.
The NCRI was set up in 2001 with a mission to bring together all the key players in research in the UK to identify where research is most needed and where it is most likely to contribute to progress. 15 organisations formed the original NCRI Partnership, providing a forum to build connections between Partners, and to establish a database of cancer research funding to understand areas of strength and weakness in the UK. More than ten years on, NCRI now have 22 Partner organisations who collectively spend more than £500m on cancer research each year. The need for coordination remains as strong as ever, and activities now include a thriving annual conference, clinical studies groups for researchers to collaborate on trial development, and a range of initiatives to boost activity within particular strands of research. View a Summary of NCRI strategic plan 2012-17 (PDF).